{
    "2019-01-07": [
        [
            {
                "time": "",
                "original_text": "医疗保健：坚守低估值与确定性 荐7股",
                "features": {
                    "keywords": [
                        "医疗保健",
                        "低估值",
                        "确定性"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗保健"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "372亿资金争夺20股：主力资金重点出击7股(名单)",
                "features": {
                    "keywords": [
                        "资金",
                        "主力",
                        "股票名单"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医疗保健：信迪利成为首个针对霍奇金淋巴瘤的PD-1国产药物 BMS获新基产品线有望进一步拓宽肿瘤免疫布局",
                "features": {
                    "keywords": [
                        "医疗保健",
                        "信迪利",
                        "PD-1",
                        "国产药物",
                        "BMS",
                        "肿瘤免疫"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗保健"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "千亿中药帝国的倒塌 康美药业现金流4年低于净利",
                "features": {
                    "keywords": [
                        "康美药业",
                        "现金流",
                        "净利润",
                        "中药"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "康美药业现金流连续4年低于净利润 被指利润虚高",
                "features": {
                    "keywords": [
                        "康美药业",
                        "现金流",
                        "净利润",
                        "利润虚高"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业:全球前沿周报-医药步入国际化元年,峭崖试飞,出清与创新皆提速",
                "features": {
                    "keywords": [
                        "医药生物",
                        "国际化",
                        "创新",
                        "出清"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}